- Home
- RNA vs GHI Comparison
RNA vs GHI Comparison
Compare RNA & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNA | GHI |
|---|---|---|
| Founded | 2012 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.5M | 173.3M |
| IPO Year | 2025 | 1998 |
Fundamental Metrics
Financial Performance| Metric | RNA | GHI |
|---|---|---|
| Price | $11.54 | $5.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 3 |
| Target Price | ★ $69.26 | $10.50 |
| AVG Volume (30 Days) | ★ 162.8K | 58.2K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | ★ 22.93% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $85,389,766.00 |
| Revenue This Year | $88.12 | $273.95 |
| Revenue Next Year | $18.11 | N/A |
| P/E Ratio | ★ N/A | $515.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.77 | $4.71 |
| 52 Week High | $73.06 | $12.27 |
Technical Indicators
Market Signals| Indicator | RNA | GHI |
|---|---|---|
| Relative Strength Index (RSI) | 28.33 | 43.82 |
| Support Level | N/A | $5.04 |
| Resistance Level | $14.05 | $5.44 |
| Average True Range (ATR) | 0.50 | 0.15 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 0.38 | 24.45 |
Price Performance
Historical ComparisonAbout RNA Avidity Biosciences Inc.
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.